Michael Pine

Mr. Pine has developed a diverse set of skills and extensive deal sheets over his 20+ years of strategic and corporate development experience working at both large and small public pharmaceutical companies. Prior to joining Eyepoint as Chief Corporate Development & Strategy Officer, Mr. Pine was Senior Vice President, Business Development & Strategy for publicly traded Medexus Pharmaceuticals, where he was responsible for a number of strategic evaluations and transactions. Prior roles included positions of increasing responsibility at Lupin (branded), Aralez, Novartis, Kos, Organon, and Pfizer. While at Novartis, Mr. Pine took on a variety of roles in order to develop a well-rounded understanding of the industry including Business Development, Marketing, Managed Markets, and Strategy & Operations.

In addition to his pharmaceutical experience, Mr. Pine began his career as an Investment Banking Financial Analyst for JP Morgan Chase. Mr. Pine has a Bachelor of Science degree from Cornell University and a Master of Business Administration degree from Columbia Business School.